ECSP034682A - Antagonistas de receptores de aminoacidos excitatorios - Google Patents
Antagonistas de receptores de aminoacidos excitatoriosInfo
- Publication number
- ECSP034682A ECSP034682A EC2003004682A ECSP034682A ECSP034682A EC SP034682 A ECSP034682 A EC SP034682A EC 2003004682 A EC2003004682 A EC 2003004682A EC SP034682 A ECSP034682 A EC SP034682A EC SP034682 A ECSP034682 A EC SP034682A
- Authority
- EC
- Ecuador
- Prior art keywords
- ancigonists
- receivers
- amino acids
- excitatory amino
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034682A true ECSP034682A (es) | 2003-08-29 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004682A ECSP034682A (es) | 2001-01-05 | 2003-07-03 | Antagonistas de receptores de aminoacidos excitatorios |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (no) |
| JP (1) | JP2004520335A (no) |
| KR (1) | KR20030066797A (no) |
| CN (1) | CN1484642A (no) |
| AR (1) | AR035679A1 (no) |
| BR (1) | BR0116672A (no) |
| CA (1) | CA2431545A1 (no) |
| CZ (1) | CZ20031856A3 (no) |
| DZ (1) | DZ3460A1 (no) |
| EA (1) | EA200300770A1 (no) |
| EC (1) | ECSP034682A (no) |
| HR (1) | HRP20030544A2 (no) |
| HU (1) | HUP0302528A2 (no) |
| IL (1) | IL156138A0 (no) |
| MX (1) | MXPA03005981A (no) |
| NO (1) | NO20032973L (no) |
| NZ (1) | NZ525821A (no) |
| PE (1) | PE20020792A1 (no) |
| PL (1) | PL361934A1 (no) |
| SK (1) | SK8242003A3 (no) |
| TW (1) | TW591023B (no) |
| WO (1) | WO2002053561A1 (no) |
| ZA (1) | ZA200304311B (no) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| IL137684A0 (en) * | 1998-02-06 | 2001-10-31 | Smithkline Beechmam Plc | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| DK1200073T3 (da) * | 1999-07-06 | 2007-05-07 | Lilly Co Eli | Selektive iGluR5-receptorantagonister til behandling af migræne |
-
2001
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Application Discontinuation
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Application Discontinuation
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
-
2002
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973L/no not_active Application Discontinuation
- 2003-07-03 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK8242003A3 (en) | 2004-01-08 |
| PE20020792A1 (es) | 2002-09-06 |
| CN1484642A (zh) | 2004-03-24 |
| TW591023B (en) | 2004-06-11 |
| ZA200304311B (en) | 2004-09-02 |
| JP2004520335A (ja) | 2004-07-08 |
| IL156138A0 (en) | 2003-12-23 |
| NO20032973D0 (no) | 2003-06-27 |
| NO20032973L (no) | 2003-06-27 |
| NZ525821A (en) | 2004-07-30 |
| KR20030066797A (ko) | 2003-08-09 |
| AR035679A1 (es) | 2004-06-23 |
| PL361934A1 (en) | 2004-10-18 |
| HRP20030544A2 (en) | 2004-08-31 |
| BR0116672A (pt) | 2003-09-23 |
| MXPA03005981A (es) | 2003-09-10 |
| HUP0302528A2 (hu) | 2003-11-28 |
| DZ3460A1 (fr) | 2002-07-11 |
| CA2431545A1 (en) | 2002-07-11 |
| EA200300770A1 (ru) | 2003-10-30 |
| CZ20031856A3 (cs) | 2003-09-17 |
| WO2002053561A1 (en) | 2002-07-11 |
| EP1351955A1 (en) | 2003-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5271657A1 (es) | Derivados de azaindol | |
| EP1602370A3 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
| HRP20020428B1 (en) | Bicyclic amino acids as pharmaceutical agents | |
| RS50352B (sr) | Monosupstituisane 3-propil gama-aminobuterne kiseline | |
| EA200300065A1 (ru) | Окисленные сложные эфиры 4-йодфениламинобензгидроксамовых кислот | |
| BR9900443A (pt) | Esteres de ácido aril acrìlico. | |
| UY27273A1 (es) | Solución oral de arilpiprazol | |
| CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
| CO5720995A2 (es) | Compuesto novedoso | |
| DE69507614D1 (de) | 3-amino-2-oxo-piperidinessigsäurederivate, die eine argininnachahmende verbindung, mit enzyminhibitorischen wirkung enthalten | |
| CY1120408T1 (el) | Βελτιωμενες φαρμακοτεχνικες μορφες | |
| AR025307A1 (es) | Compuesto de liberacion sostenida de un peptido, microparticulas, composicion farmaceutica y el uso de dicho compuesto para la fabricacion de un medicamento | |
| BR0002073A (pt) | Processo para a preparação de um composto quiral | |
| MY133507A (en) | New peroxy-carboxylic acid and aqueous compositions thereof | |
| CO5280222A1 (es) | Composicion farmaceutica que comprende pemetrexed | |
| ATE322487T1 (de) | Hydroxamsäure-derivate | |
| ES2190422T3 (es) | Antagonistas selectivos de receptores de adenosina a2b. | |
| IT1319234B1 (it) | Processo di preparazione di gabapentina. | |
| AR021232A1 (es) | Procedimiento de preparacion de metionina. | |
| ES2422081T3 (es) | Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales | |
| DE69327890D1 (de) | Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen | |
| BR0212772A (pt) | Processo para a preparação de repaglinida | |
| DE60129442D1 (de) | Sulphonsäurederivate von hydroxamsäuren und deren verwendung in medizinischen produkten | |
| ECSP034682A (es) | Antagonistas de receptores de aminoacidos excitatorios | |
| SE9902364D0 (sv) | New process |